Publications:325
Accepting New Patients
Mount Sinai DoctorsTreats Children & Adults
Accepting New PatientsMichael Gorin, MD
Urology
Book an Appointment
About Me
Michael A. Gorin, M.D. is an Associate Professor within the Milton and Carroll Petrie Department of Urology at the Icahn School of Medicine at Mount Sinai. Dr. Gorin cares for patients with a range of urologic conditions, including enlarged prostate symptoms, kidney stones, kidney tumors, and prostate cancer. As a fellowship-trained endourologist, Dr. Gorin offers patients the most advanced minimally invasive treatment options. Dr. Gorin currently sees patients at locations on Long Island and in New York City.
In addition to being a skilled surgeon, Dr. Gorin is also an accomplished clinical researcher. He is widely recognized for his work studying the use of molecular imaging in the diagnosis and management of urologic malignancies. To his credit, Dr. Gorin was part of the first clinical team to study PSMA-targeted PET imaging of prostate cancer with PYLARIFY ([18F]DCFPyL). Additionally, he played an integral role in the design and conduct of two multicenter clinical trials that led to the approval of this novel PET radiotracer by the United States Food and Drug Administration. Since its approval in May 2021, PYLARIFY has been used to image tens of thousands of men with prostate cancer.
Dr. Gorin has also made significant contributions to the field of urology through his research on prostate cancer screening, active surveillance, and focal therapy. Notably, Dr. Gorin was one of the first urologists in the United States to perform MRI-guided prostate biopsy using the transperineal approach. He is responsible for generating much of the clinical data supporting this safer and more accurate method of prostate biopsy. Dr. Gorin frequently gives invited talks on his work in this arena and proctors other urologists learning to perform the diagnostic techniques he helped pioneer.
To date, Dr. Gorin has published over 300 articles in peer-reviewed journals with collaborators from around the world. Additionally, he has contributed to multiple medical textbooks, including chapters in Campbell-Walsh-Wein Urology, The 5-Minute Urology Consult, and Gray's Anatomy. In July 2022, Dr. Gorin was named Editor-in-Chief of BJUI Compass, the open-access companion journal to the British Journal of Urology International. Dr. Gorin also serves on the editorial boards of several other journals, including UROLOGY (the Gold Journal), Urologic Oncology, and the World Journal of Urology. Dr. Gorin has received numerous honors and awards for his scholarly work, including the Drs. Carl and Barbara Alving Endowed Award for Outstanding Biomedical Research from the University of Miami Leonard M. Miller School of Medicine and the William F. Rienhoff, Jr., M.D. Scholar Award from Johns Hopkins University School of Medicine.
Dr. Gorin attended college at the University of Michigan, earning a Bachelor of Science in Cellular and Molecular Biology. He then attended medical school at the University of Miami Leonard M. Miller School of Medicine, where he graduated as an inductee to the Alpha Omega Alpha Honor Medical Society. Following medical school, Dr. Gorin completed a general surgery internship, urology residency, and fellowship in endoscopic and minimally invasive urology at the world-renowned James Buchanan Brady Urological Institute at Johns Hopkins University School of Medicine.
Language
Position
Hospital Affiliations
- Mount Sinai South Nassau
- Mount Sinai Queens
- The Mount Sinai Hospital
About Me
Michael A. Gorin, M.D. is an Associate Professor within the Milton and Carroll Petrie Department of Urology at the Icahn School of Medicine at Mount Sinai. Dr. Gorin cares for patients with a range of urologic conditions, including enlarged prostate symptoms, kidney stones, kidney tumors, and prostate cancer. As a fellowship-trained endourologist, Dr. Gorin offers patients the most advanced minimally invasive treatment options. Dr. Gorin currently sees patients at locations on Long Island and in New York City.
In addition to being a skilled surgeon, Dr. Gorin is also an accomplished clinical researcher. He is widely recognized for his work studying the use of molecular imaging in the diagnosis and management of urologic malignancies. To his credit, Dr. Gorin was part of the first clinical team to study PSMA-targeted PET imaging of prostate cancer with PYLARIFY ([18F]DCFPyL). Additionally, he played an integral role in the design and conduct of two multicenter clinical trials that led to the approval of this novel PET radiotracer by the United States Food and Drug Administration. Since its approval in May 2021, PYLARIFY has been used to image tens of thousands of men with prostate cancer.
Dr. Gorin has also made significant contributions to the field of urology through his research on prostate cancer screening, active surveillance, and focal therapy. Notably, Dr. Gorin was one of the first urologists in the United States to perform MRI-guided prostate biopsy using the transperineal approach. He is responsible for generating much of the clinical data supporting this safer and more accurate method of prostate biopsy. Dr. Gorin frequently gives invited talks on his work in this arena and proctors other urologists learning to perform the diagnostic techniques he helped pioneer.
To date, Dr. Gorin has published over 300 articles in peer-reviewed journals with collaborators from around the world. Additionally, he has contributed to multiple medical textbooks, including chapters in Campbell-Walsh-Wein Urology, The 5-Minute Urology Consult, and Gray's Anatomy. In July 2022, Dr. Gorin was named Editor-in-Chief of BJUI Compass, the open-access companion journal to the British Journal of Urology International. Dr. Gorin also serves on the editorial boards of several other journals, including UROLOGY (the Gold Journal), Urologic Oncology, and the World Journal of Urology. Dr. Gorin has received numerous honors and awards for his scholarly work, including the Drs. Carl and Barbara Alving Endowed Award for Outstanding Biomedical Research from the University of Miami Leonard M. Miller School of Medicine and the William F. Rienhoff, Jr., M.D. Scholar Award from Johns Hopkins University School of Medicine.
Dr. Gorin attended college at the University of Michigan, earning a Bachelor of Science in Cellular and Molecular Biology. He then attended medical school at the University of Miami Leonard M. Miller School of Medicine, where he graduated as an inductee to the Alpha Omega Alpha Honor Medical Society. Following medical school, Dr. Gorin completed a general surgery internship, urology residency, and fellowship in endoscopic and minimally invasive urology at the world-renowned James Buchanan Brady Urological Institute at Johns Hopkins University School of Medicine.
Language
Position
Hospital Affiliations
- Mount Sinai South Nassau
- Mount Sinai Queens
- The Mount Sinai Hospital
Clinical Focus
- Benign Prostatic Hyperplasia
- Bladder Cancer
- Bladder Stone
- Difficulty Urinating
- Elevated PSA
- Flank pain
- Fusion Prostate Biopsy
- Hydrocele/Varicocele
- Hydronephrosis
Show More
Education
MD, University of Miami School of Medicine
Internship, Surgery (General Surgery)
Johns Hopkins Hospital
Internship, Surgery (General Surgery)
Johns Hopkins University School of Medicine
Residency, Urology
Johns Hopkins University School of Medicine
Residency, Urology
Johns Hopkins Hospital
Fellowship, Endourology/Minimally Invasive Surgery
Johns Hopkins Hospital
Certifications
American Board of Urology
Locations
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
Patients with Cigna Medicare Advantage or Humana Medicare Advantage insurance: Please read this important message before booking to find out if out-of-network costs may apply to your next visit.
- Mount Sinai Doctors - Greenlawn5 Cuba Hill Road, Greenlawn, NY, 11740
- Mount Sinai Doctors - Midtown Urology625 Madison Avenue, 2nd Floor, New York, NY, 10022
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- A Novel Machine Learning-based Predictive Model of Clinically Significant Prostate Cancer and Online Risk Calculator. Flavio Vasconcelos Ordones, Paulo Roberto Kawano, Lodewikus Vermeulen, Ali Hooshyari, David Scholtz, Peter John Gilling, Darren Foreman, Basil Kaufmann, Cedric Poyet, Michael Gorin, Abner Macola Pacheco Barbosa, Naila Camila da Rocha, Luis Gustavo Modelli de Andrade. Urology
- Lack of effect of renal function on uptake of <sup>99m</sup>Tc-sestamibi in renal masses. Alireza Amindarolzarbi, Kendall Satcowitz, Adham Khalil, Sena Osman, Salikh Murtazaliev, Anas Al-Zubaidi, Benjamin L. Viglianti, Lilja B. Solnes, Basil Kaufmann, Sara Sheikhbahaei, Christian P. Pavlovich, Jorge D. Oldan, Thad Benefield, Nirmish Singla, Michael A. Gorin, Steven P. Rowe. Nuclear Medicine Communications
- The potential of generative AI with prostate-specific membrane antigen (PSMA) PET/CT: challenges and future directions. Md Zobaer Islam, Ergi Spiro, Pew Thian Yap, Michael A. Gorin, Steven P. Rowe. Medical Review
Patient Experience Star Ratings and Comments
The Patient Experience Star Rating reflects our patients’ perception of how well their Mount Sinai provider communicated with them during an office visit. The Star Rating is based on patient responses to three questions on a patient experience survey, a standardized questionnaire sent to verified patients and distributed by a third party vendor, Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Gorin during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Qessential
- Capvision
- Tegus, Inc.
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
- Central Nassau Ambulatory Surgery Center
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Gorin during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Qessential
- Capvision
- Tegus, Inc.
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
- Central Nassau Ambulatory Surgery Center
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.